gabapentin
Generic: gabapentin
Labeler: advanced rx of tennessee, llcDrug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
advanced rx of tennessee, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
gabapentin 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
80425-0033
Product ID
80425-0033_2e20f1f6-cc39-307e-e063-6394a90a6805
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090858
Listing Expiration
2026-12-31
Marketing Start
2011-01-29
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
804250033
Hyphenated Format
80425-0033
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA090858 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (80425-0033-1)
- 60 CAPSULE in 1 BOTTLE (80425-0033-2)
- 90 CAPSULE in 1 BOTTLE (80425-0033-3)
- 40 CAPSULE in 1 BOTTLE (80425-0033-4)
- 120 CAPSULE in 1 BOTTLE (80425-0033-5)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2e20f1f6-cc39-307e-e063-6394a90a6805", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310431"], "spl_set_id": ["afc83432-8fce-6d2a-e053-2a95a90ae73f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Advanced Rx of Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (80425-0033-1)", "package_ndc": "80425-0033-1", "marketing_start_date": "20110129"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (80425-0033-2)", "package_ndc": "80425-0033-2", "marketing_start_date": "20110129"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (80425-0033-3)", "package_ndc": "80425-0033-3", "marketing_start_date": "20110129"}, {"sample": false, "description": "40 CAPSULE in 1 BOTTLE (80425-0033-4)", "package_ndc": "80425-0033-4", "marketing_start_date": "20110129"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (80425-0033-5)", "package_ndc": "80425-0033-5", "marketing_start_date": "20250218"}], "brand_name": "Gabapentin", "product_id": "80425-0033_2e20f1f6-cc39-307e-e063-6394a90a6805", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "80425-0033", "generic_name": "Gabapentin", "labeler_name": "Advanced Rx of Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA090858", "marketing_category": "ANDA", "marketing_start_date": "20110129", "listing_expiration_date": "20261231"}